Title |
A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries
|
---|---|
Published in |
Journal of the International AIDS Society, September 2010
|
DOI | 10.1186/1758-2652-13-35 |
Pubmed ID | |
Authors |
Brenda Waning, Ellen Diedrichsen, Suerie Moon |
Abstract |
Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid scale up of HIV/AIDS treatment in developing countries though provision of low-priced, quality-assured medicines. The legal framework in India that facilitated such production, however, is changing with implementation of the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights, and intellectual property measures being discussed in regional and bilateral free trade agreement negotiations. Reliable quantitative estimates of the Indian role in generic global ARV supply are needed to understand potential impacts of such measures on HIV/AIDS treatment in developing countries. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 2 | 50% |
Unknown | 2 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Scientists | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Germany | 1 | <1% |
Tanzania, United Republic of | 1 | <1% |
Unknown | 158 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 30 | 19% |
Student > Master | 26 | 16% |
Student > Ph. D. Student | 22 | 14% |
Student > Bachelor | 20 | 12% |
Student > Postgraduate | 10 | 6% |
Other | 24 | 15% |
Unknown | 29 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 24% |
Social Sciences | 25 | 16% |
Business, Management and Accounting | 9 | 6% |
Agricultural and Biological Sciences | 9 | 6% |
Economics, Econometrics and Finance | 8 | 5% |
Other | 36 | 22% |
Unknown | 36 | 22% |